Core Viewpoint - Vitasoy International Holdings Limited reported a 6% decrease in revenue for the interim period ending September 30, 2025, primarily due to challenges in the mainland China market, while maintaining a gross margin of 51.1% and an operating profit margin of 7.6% [1] Group 1: Financial Performance - The company recorded a profit attributable to equity holders of HKD 172 million [1] - The board declared an interim dividend of HKD 0.04 per ordinary share, unchanged from the previous interim period [1] - The operating profit margin for the mainland China business was maintained at 11% due to cost optimization measures [2] Group 2: Market Performance - The mainland China business faced revenue decline due to shrinking traditional retail channel sales, although this was partially offset by robust growth in the omnichannel approach [1][2] - In Hong Kong, the beverage business continued to strengthen its leadership position in the non-alcoholic beverage market, despite challenges in the Vitasoy Tian Di business and export to the U.S. [2] - The Australian and New Zealand markets saw a 5% sales growth in local currency, with improved profitability and a significant reduction in operating losses to HKD 22 million [3] Group 3: Product Innovation and Strategy - The company focused on enhancing commercial execution and product innovation, leading to increased market share for Vitasoy's soy and plant-based milk products [1] - New product launches, such as Vitasoy's low-sugar white peach soy milk and lemon tea, contributed to market share growth in the ready-to-drink tea category [1][2] - In the Philippines, the plant-based category has been growing steadily at a double-digit rate, driven by oat and almond products [3]
维他奶集团罗友礼:对持续扩大规模的长期潜力充满信心